PBI logo

PBI

Pitney Bowes Inc.

$17.50
+$0.12(+0.69%)
75
Overall
80
Value
91
Tech
55
Quality
How is this score calculated?
Market Cap
$2.37B
Volume
8.01M
52W Range
$8.95 - $16.56
Target Price
$17.14

Company Overview

Mkt Cap$2.37BPrice$17.50
Volume8.01MChange+0.69%
P/E Ratio16.4Open$17.31
Revenue$1.9BPrev Close$17.38
Net Income$144.7M52W Range$8.95 - $16.56
Div Yield0.40%Target$17.14
Overall75Value80
Quality55Technical91

No chart data available

About Pitney Bowes Inc.

Pitney Bowes Inc., operates as a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to small businesses, large enterprises, and government entities around the world. It operates through SendTech Solutions and Presort Services segments. The SendTech Solutions segment provides physical and digital shipping and mailing technology solutions, and other applications for sending, tracking and receiving of letters, parcels and flats, supplies, and maintenance services, as well as financing alternatives to finance equipment and product purchases. The Presort Services segment offers mail sortation services, which allow clients to qualify volumes of first-class mail, marketing mail, marketing mail flats, and bound printed matter for postal workshare discounts. It markets its products, solutions, and services through direct and inside sales force, global and regional partner channels, direct mailings, and digital channels. The company was formerly known as Pitney Bowes Postage Meter Company. Pitney Bowes Inc. was incorporated in 1920 and is headquartered in Stamford, Connecticut.

Sector: Industrials
Industry: Business Equipment

Latest News

Paradigm Biopharmaceuticals Updates Director Matthew Fry’s Option Holdings

The latest update is out from Paradigm Biopharmaceuticals ( ($AU:PAR) ). Paradigm Biopharmaceuticals has disclosed a change in the indirect interes...

TipRanks Australian Auto-Generated Newsdesk2 days ago

Paradigm Biopharmaceuticals updates market on director Paul Rennie’s expanded option holdings

TipRanks Australian Auto-Generated Newsdesk2 days ago

Paradigm Biopharmaceuticals Seeks ASX Quotation for Over 10 Million New Shares

TipRanks Australian Auto-Generated Newsdesk2 days ago

Paradigm Biopharmaceuticals’ Top 20 Option Holders Control Majority of PAROPTWC Register

TipRanks Australian Auto-Generated Newsdesk3 days ago

Paradigm Biopharmaceuticals Seeks ASX Quotation for 117 Million New Options

TipRanks Australian Auto-Generated Newsdesk3 days ago
ABCD
1SymbolPriceChangeVol
2PBI$17.50+0.7%8.01M
3
4
5
6

Get Pitney Bowes Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.